3/12/2024 | 382290000019 | REFERENCE STANDARD (DESBENZOYL HYDROXYBENZ/YL NEPAFENAC IMP 10 MG * FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 322 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/28/2024 | 382290000019 | REFERENCE STANDARD*(ISOMER IMPURTY C1-C2 / 20 MG*FREE SAMPLE) | 2 | UNIT | 545 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/19/2024 | 382290000019 | REFERENCE STANDARD (NEPAFENAC IMP C 10 MG/ *FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 143 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/12/2024 | 382290000019 | REFERENCE STANDARD (AMINO BENZOYL ALPHA B/ENZENEACETAMIDE IMP 10 MG * FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 60 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/20/2024 | 382290000019 | REFERENCE STANDARD (LENALIDOMIDE IMPURTY /10 MG) | 1 | UNIT | 118 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/12/2024 | 382290000019 | REFERENCE STANDARD (AMINOBENZOPHENONE IMP/ 10 MG * FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 60 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/12/2024 | 382290000019 | REFERENCE STANDARD (BENZOYLOXINDOLE IMP 1/0 MG * FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 60 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/12/2024 | 382290000019 | REFERENCE STANDARD (NITROSODILSOPLAMINE I/MP 50 MG *FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 103 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/25/2024 | 382290000019 | REFERENCE STANDARD (NITROSODIMETHYLLAMINE/ D6 1MG METHANOL IMP 1 ML* FOR R&D ANALYSIS PURPOSES) | 1 | UNIT | 93 | N/A | ABDİ İBRAHİM İLAÇ SANAYİ VE TİCARET ANONİM ŞİRKETİ |
3/28/2024 | 382290000019 | LABORATORY CHEMICAL ((1.125 MG=6 PIECES)) ((REFERENCE STANDARD))-I(IT WAS NOT IN THE SCOPE OF 2024/19 NOTIFICATION+R-IT IS NOT A MEDICAL DIAGNOSIS KIT.)) | 6 | UNIT | 1054 | N/A | GATES KİMYA GIDA İLETİŞİM SANAYİ VE TİCARET LİMİTED ŞİRKETİ |